{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 3005"}, "official-title": {"#tail": "\n\t", "quote": {"#tail": " products in diagnostic tests.", "#text": "research use\n\t\t  only"}, "#text": "To amend chapter V of the Federal Food, Drug, and\n\t\t  Cosmetic Act to permit the sale of, and access to, "}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130802", "#text": "August 2, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t himself and ", "#text": "Mr. Burgess", "@name-id": "B001248"}, "cosponsor": {"#tail": ") introduced the\n\t\t\t following bill; which was referred to the ", "#text": "Ms. Speier", "@name-id": "S001175"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HB9747C5510D94C45A970924E4FE0D6F2", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Medical Testing Availability Act of\n\t\t\t 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HC8502C575282435C88FE5D44E081CAB5"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following\n\t\t\t subsection:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 520 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:520"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 360j", "@value": "usc/21/360j"}, "@parsable-cite": "usc/21/360j", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Clarification\n\t\t\t regarding research use only products"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "subsection": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "(o)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Products with\n\t\t\t\tresearch use only labeling"}, "paragraph": [{"#tail": "\n          ", "@id": "H14AA9990CB1B4D3E8E73D582E3D57699", "enum": {"#tail": "\n            ", "#text": "(1)"}, "header": {"#tail": "\n            ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "A product whose\n\t\t\t\tlabeling bears the statement described in ", "external-xref": {"#tail": " of title 21,\n\t\t\t\tCode of Federal Regulations, as in effect on the date of the enactment of this\n\t\t\t\tsubsection, may not be deemed to be misbranded under this Act on the basis that\n\t\t\t\tthe manufacturer or distributor of the product\u2014", "@parsable-cite": "usc/21/809", "#text": "section 809.10(c)(2)(i)", "@legal-doc": "usc"}, "@display-inline": "yes-display-inline"}, "#text": "\n            ", "subparagraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "sells the product to an end user who uses\n\t\t\t\tthe product in a manner inconsistent with such statement; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(A)"}, "#text": "\n              ", "@id": "H64443D4A383F43E2B4213EF9720D65E2", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "engages in\n\t\t\t\tbusiness communications regarding the product with an end user of the\n\t\t\t\tproduct."}, "enum": {"#tail": "\n              ", "#text": "(B)"}, "@id": "HFC968723BFA347EA853EEDFD543BE112", "#text": "\n              "}]}, {"#tail": "\n          ", "@id": "HB406981C74E14A04936F99134EB4F843", "enum": {"#tail": "\n            ", "#text": "(2)"}, "header": {"#tail": "\n            ", "#text": "Business\n\t\t\t\tcommunications defined"}, "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:520/ss:o/p:1", "@proposed": "true"}, "term": {"#tail": ", with respect to\n\t\t\t\ta product with labeling described in ", "#text": "business communications"}, "#text": "In\n\t\t\t\tthis subsection, the term ", "@display-inline": "yes-display-inline"}, "#text": "\n            ", "subparagraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "means oral,\n\t\t\t\twritten, or electronic contact between a manufacturer or distributor of such\n\t\t\t\tproduct and an end user regarding the functioning of such product; and"}, "enum": {"#tail": "\n              ", "#text": "(A)"}, "@id": "H8E2DEA37FCA643C085B5462E87684453", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "includes any such\n\t\t\t\tcontact consisting of technical support, customer service, assistance with the\n\t\t\t\tinstallation of such product, communication relating to ensuring the\n\t\t\t\tperformance of the product, and other similar contacts."}, "enum": {"#tail": "\n              ", "#text": "(B)"}, "@id": "H163E27908E8646B78B41A2A47763D6E5", "#text": "\n              "}]}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "This\n\t\t\t\tsubsection shall cease to be effective on the last day of the five-year period\n\t\t\t\tbeginning on the date of enactment of this section."}, "enum": {"#tail": "\n            ", "#text": "(3)"}, "header": {"#tail": "\n            ", "#text": "Sunset"}, "#text": "\n            ", "@id": "HFB4756C3FF3D4CFC9EACEF0B3C721927"}], "#text": "\n          ", "@id": "H7BE287051A284B87B9ECF4F0EA56BD5E"}, "#text": "\n\t\t\t\t", "@id": "HB86032CC870D4518BD2CA99B9F73B431"}, "#text": "\n      ", "@id": "H5CEDF01B45AC4F1A967259935DCA9F27"}], "#text": "\n\t\t", "@id": "HDDC0FDDBD17F42E1843ED9FF72944B3A"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-08-02"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 3005 IH: Medical Testing Availability Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}